Aycan Asik

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 07, 2026
Temozolomide and ruxolitinib combination modulates miRNA-associated regulatory networks in glioblastoma stem cells.

|Apr 21, 2026
Correction: The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.

|Jan 23, 2026
The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells.

Neslihan Pinar Ozates, Bakiye Goker Bagca, Aycan Asik

|Nov 05, 2025
Defeating miR-181a-3p may potentiate the effect of paclitaxel on G2/M arrest in breast cancer stem cells.

Aycan Asik, Bakiye Goker Bagca, Neslihan Pinar Ozates

|Jun 30, 2023
The effects of PKI-402 on breast tumor models' radiosensitivity via dual inhibition of PI3K/mTOR.

Roya Gasimli, Cagla Kayabasi, Besra Ozmen Yelken

|Aug 27, 2018
The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer.

Fatma Sogutlu, Cagla Kayabasi, Besra Ozmen Yelken

Pageof 1

Frequent Collaborators

5 joint publications

Cumhur Gunduz

4 joint publications

Cigir Biray Avci

4 joint publications

Neslihan Pinar Ozates

4 joint publications

Bakiye Goker Bagca